We are live on ! Find out more
BCPEMI

Bain Capital Public Equity Management II Portfolio holdings

AUM $62.1M
1-Year Est. Return 25.46%
This Fund
S&P 500
This Quarter Est. Return
+29.54%
1 Year Est. Return
+25.46%
3 Year Est. Return
+200.73%
5 Year Est. Return
+313.45%
10 Year Est. Return
AUM
$1.96B
AUM Growth
+$442M
Cap. Flow
+$138M
Cap. Flow %
7.07%
Top 10 Hldgs %
47.99%
Holding
59
New
17
Increased
11
Reduced
11
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 40.94%
2 Consumer Discretionary 21.21%
3 Financials 16.23%
4 Healthcare 10.45%
5 Consumer Staples 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDGR icon
26
Schrodinger
SDGR
$1.4B
$32M 1.63%
403,689
-177,167
-31% -$11.1M
DGNR.U
27
DELISTED
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
$28M 1.43%
2,000,000
LESL icon
28
Leslie's
LESL
$12.4M
$26.6M 1.36%
+47,861
New +$21.5M
UBER icon
29
Uber
UBER
$160B
$23M 1.17%
450,212
AZN icon
30
AstraZeneca
AZN
$246B
$15.7M 0.8%
+157,494
New +$16.7M
TBIO
31
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$11.6M 0.59%
627,387
+389,884
+164% +$6.98M
STNE icon
32
StoneCo
STNE
$2.42B
$10.6M 0.54%
+126,256
New +$8.46M
CLDR
33
DELISTED
Cloudera, Inc.
CLDR
$9.55M 0.49%
686,813
AFMD
34
DELISTED
Affimed
AFMD
$7.96M 0.41%
136,790
-78,061
-36% -$3.68M
IQV icon
35
IQVIA
IQV
$40.1B
$6.8M 0.35%
37,974
+1
+0% +$169
SNY icon
36
Sanofi
SNY
$104B
$4.55M 0.23%
93,750
-155,419
-62% -$7.67M
CRIS icon
37
Curis
CRIS
$4.83M
$4.52M 0.23%
1,380
+1,272
+1,178% +$1.53M
HZNP
38
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2M 0.1%
+3,700
New +$275K
SPY icon
39
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$1.14M 0.06%
5,750
+2,311
+67% +$820K
MRNA icon
40
PUT
Moderna
MRNA
$24.2B
$994K 0.05%
+250
New +$25.3K
DVAX
41
DELISTED
Dynavax Technologies
DVAX
$574K 0.03%
128,912
KA
42
DELISTED
Kineta, Inc. Common Stock
KA
$533K 0.03%
4,476
-234
-5% -$35.6K
GBT
43
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
$315K 0.02%
+1,000
New +$49.3K
ADPT icon
44
Adaptive Biotechnologies
ADPT
$4.04B
-497,449
Closed -$24.2M
AMZN icon
45
Amazon
AMZN
$2.94T
-344,520
Closed -$54.2M
ASMB icon
46
Assembly Biosciences
ASMB
$540M
-29,834
Closed -$5.89M
BABA icon
47
Alibaba
BABA
$306B
-160,112
Closed -$47.1M
BALL icon
48
Ball Corp
BALL
$16.6B
-695,427
Closed -$57.8M
DKNG icon
49
DraftKings
DKNG
$12.6B
-623,875
Closed -$36.7M
EFA icon
50
PUT
iShares MSCI EAFE ETF
EFA
$79.9B
-5,000
Closed -$430K

Similar funds

Bain Capital Public Equity Management II's Q4 2020 Portfolio in Review

As of Q4 2020, Bain Capital Public Equity Management II held 59 positions worth $1.96B, up 29% from $1.51B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Bain Capital Public Equity Management II deployed $138M of net new capital in Q4 2020, opening 17 new positions and adding to 11 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 185,020 shares worth $69.2M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was DocuSign, an estimated $112M trimmed.

  • Bain Capital Public Equity Management II's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 185,020 shares worth $69.2M.
  • Bain Capital Public Equity Management II added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020, an estimated $58.2M increase.
  • Bain Capital Public Equity Management II's biggest Q4 2020 reduction was DocuSign, cutting an estimated $112M.
  • Bain Capital Public Equity Management II fully exited Fidelity National Information Services in Q4 2020, selling an estimated $72.5M.
  • Bain Capital Public Equity Management II's ten largest holdings make up 48% of its $1.96B portfolio in Q4 2020.
  • Bain Capital Public Equity Management II opened 17 new positions and closed 16 in Q4 2020.
  • Bain Capital Public Equity Management II's portfolio value rose 29% quarter-over-quarter to $1.96B.

Based on Bain Capital Public Equity Management II's 13F filing for Q4 2020, filed 16 Feb 2021.